<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">Coronavirus pandemic also fuelled a surge in counterfeit medicine sales — a parallel pandemic of fake “essential” medicines (including the COVID-19 candidate drug chloroquine and hydroxychloroquine) and other medical supplies. Since COVID-19 was declared as a pandemic, a global pharmaceutical crimes police unit has captured tens of thousands of counterfeit medicines and medical supplies claimed to cure the coronavirus. This is mainly attributed to a decline in the production capacities of world's two largest producers of medical supplies, China and India, following lockdown. After hydroxychloroquine was claimed effective for COVID-19 treatment, there was a surge in the demand for the drug and a decline in international supplies,
 <xref rid="bib59" ref-type="bibr">
  <sup>59</sup>
 </xref> posing risk of drug shortages. The African nations will especially be affected if this trend continues because Indian companies supply up to 20% of all medical supplies to Africa, where the region carries a high share of global malaria burden (&gt;90% of global cases and deaths).
 <xref rid="bib60" ref-type="bibr">
  <sup>60</sup>
 </xref> Also, reports of distribution of faulty coronavirus testing kits and substandard protective gears have dominated the news amid the COVID-19 pandemic.
</p>
